Sponsor or institution
Clinical trials and research at West China Hospital
As of November 12, 2026, Find a Trial lists 126 clinical trials run by West China Hospital that are recruiting, in China. By phase: Phase 1 (29), Phase 2 (25), Phase 1/2 (12), Phase 3 (6). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 126Clinical trials
- 1Country
Newest trials
All recruiting trials (126)
-
Neoadjuvant Cryo-Thermal Ablation with Toripalimab and Chemo for Resectable NSCLC
This study tests whether using Cryo-Thermal Ablation before chemo-immunotherapy helps people with resectable NSCLC see better outcomes.
-
Tai Chi during radiotherapy for head and neck cancer fatigue
This trial tests whether a 12-week Yang-style Tai Chi program added to usual care can reduce cancer-related fatigue in adults with head and neck cancer undergoing radiotherapy.
-
Wireless home prehabilitation for older adults with NSCLC awaiting lung surgery
This study tests whether a personalized home exercise program guided by wearable devices can improve lung function for older NSCLC patients preparing for curative lung surgery.
-
First-line combo therapy with GnP, SHR-1701, and Apatinib for metastatic pancreatic cancer
This trial tests whether adding SHR-1701 and Apatinib to standard GnP can safely and effectively treat previously untreated metastatic pancreatic cancer.
-
Early warning and stratified diagnosis of postoperative respiratory failure using ventilator waveform features
This study tests whether patterns in ventilator waveforms can predict and categorize risk of breathing failure after surgery for adults on mechanical ventilation.
-
JWK001 subretinal therapy for neovascular AMD
This study tests a single subretinal dose of JWK001 at different levels in people with wet age-related macular degeneration who have previously responded to anti-VEGF treatment.
-
Online Sharing for Head & Neck Cancer Support
A mobile app designed for adults with head and neck cancer undergoing radiotherapy to see if daily social sharing and peer interaction can help reduce psychological distress.
-
YMN-136 vaccine for advanced liver, biliary tract, and pancreatic cancers
A first-in-human dose-escalation study tests whether the YMN-136 vaccine is safe and tolerable for adults with unresectable advanced liver, biliary tract, or pancreatic cancers who have progressed on standard therapies or cannot receive them.
-
NeoOVSV mRNA Vaccine for ovarian cancer after surgery
We’re testing a novel mRNA vaccine added to standard therapy to see if it’s safe and can help patients with stage II/III ovarian cancer after surgery.
-
Pre-hepatectomy rehabilitation with mazdutide for obese MASLD donors
This trial tests whether adding mazdutide to a structured lifestyle plan helps overweight MASLD donors lose liver fat faster to become eligible for donation.
-
Vericiguat to slow calcific aortic valve narrowing
This trial tests whether vericiguat can slow the progression of mild-to-moderate calcific aortic valve stenosis compared with placebo.
-
Skin spray with superoxide dismutase to prevent radiation dermatitis in head and neck cancer
This study tests whether a topical superoxide dismutase spray can help prevent acute skin irritation in people with head and neck cancer undergoing radiotherapy.
-
Canagliflozin added to immunotherapy for advanced solid tumors
This study tests whether adding canagliflozin to tislelizumab-based immunotherapy helps people with unresectable or metastatic solid tumors.
-
BiTE therapy for chronic active antibody-mediated rejection after kidney transplant
This study tests whether a BCMA×CD3 Bispecific T-cell Engager can help kidney transplant patients with chronic active antibody-mediated rejection.
-
NeoOVIV: a personalized mRNA vaccine plus standard therapy after ovarian cancer surgery
A one-arm study tests a personalized mRNA vaccine (NeoOVIV) given with standard chemotherapy and a PD-1 blocker to see if it is safe and can trigger an immune response in women with stage II/III ovarian cancer after surgery.
-
Low- vs High-Dose Sirolimus With Prednisolone for KHE/KMP in Children
This trial tests whether a lower dose of sirolimus with prednisolone works as well as a higher dose with prednisolone for kids with Kaposiform Hemangioendothelioma and Kasabach-Merritt phenomenon.
-
First-line chemo with hepatic arterial infusion plus Envafolimab and Lenvatinib for unresectable biliary tract cancer
This trial tests a first-line treatment combining hepatic arterial infusion chemotherapy with Envafolimab and Lenvatinib to see if it helps patients with unresectable biliary tract cancer.
-
Akkermansia muciniphila topical probiotic to prevent and treat radiation skin injury
A topical probiotic made from inactivated Akkermansia muciniphila is being tested to see if it is safe and tolerable for people getting radiotherapy for breast or head/neck cancers, to prevent or lessen radiation-induced skin damage.
-
Intratumoral EDS01 plus toripalimab for recurrent or metastatic head and neck cancer
This phase 1 study tests whether directly injecting a gene‑therapy endostatin product (EDS01) into a tumor, together with the PD-1 inhibitor toripalimab, is safe and shows early signs of activity in adults with recurrent or metastatic head and neck cancer after platinum therapy.
-
Early LDL-C lowering with evolocumab after ACS to see if it slows plaque progression
This trial tests whether starting evolocumab soon after a heart attack or unstable angina, in addition to standard therapy, reduces non-culprit plaque growth over a year.
-
NALIRIFOX plus adebrelimab and PULSAR as first-line treatment for advanced pancreatic cancer
This study tests a combination of NALIRIFOX chemotherapy with adebrelimab and PULSAR as first-line therapy for locally advanced unresectable or metastatic pancreatic ductal adenocarcinoma to see if it is safe and shows initial signs of effectiveness.
-
Structured Active Follow-up After Thyroid Surgery
This study tests a structured, proactive follow-up program to help people after thyroid cancer surgery manage medications, monitor for recurrence, and address complications.
-
IL-22BP mRNA peptide therapy for advanced solid tumors
A phase 1 study tests a new peptide-delivered IL-22BP mRNA treatment to see if it is safe and if it has any early signs of shrinking or stopping advanced solid tumors in adults.
-
Pre-surgery immune checkpoint therapy plus mitochondrial vaccine for operable head and neck cancer
This trial will try a mitochondrial vaccine together with immune checkpoint drugs before and after surgery to see if it helps people with IMP3-positive, operable locally advanced head and neck cancer.
-
CFH protein delivered by ice microneedles to prevent radiation-related skin fibrosis
This phase 1 test gives CFH protein with ice microneedle patches to people with head and neck squamous cell carcinoma getting postoperative radiotherapy to see if it is safe and may prevent radiation-related skin fibrosis.
-
Irradiated tumor-and-stroma vaccine for advanced solid tumors
This Phase 1 test will try an irradiated vaccine made from tumor cells and nearby stromal cells, with or without GM-CSF, to see if it is safe and can stimulate the immune system in people with advanced solid tumors.
-
Intranasal WSK-IM05 vaccine plus tislelizumab before surgery for HPV‑positive oropharyngeal cancer
This phase I trial will see if an intranasal WSK‑IM05 vaccine given with the PD‑1 drug tislelizumab before surgery helps people with resectable HPV‑positive oropharyngeal cancer.
-
Intratumoral injection of mechanically reprogrammed macrophage-derived exosomes for advanced solid tumors
This trial will test whether injecting mechanically reprogrammed macrophage-derived exosomes directly into tumors is safe and tolerable in adults 18–65 with advanced solid tumors who have no standard treatment options.
-
Intratumoral Au-TMP with Radiotherapy and Anti-PD-1 (Toripalimab) for Advanced Melanoma
This trial will test whether a melanoma-targeted gold nanoparticle injected into tumors, combined with focused radiotherapy and the anti-PD-1 drug toripalimab, is safe for adults with unresectable advanced melanoma.
-
IMP3-saRNA (YMN-136) vaccine for advanced non-small cell lung cancer
This phase 1 study will test whether the IMP3-saRNA (YMN-136) vaccine is safe and shows early anti-tumor activity in adults with advanced non-small cell lung cancer whose tumors express IMP3 and who have exhausted or cannot take standard treatments.
-
AI-designed pan-cancer neoantigen mRNA vaccine (PAN-NeoVax) for adults with advanced solid tumors
This study will test whether an AI-designed pan-cancer neoantigen mRNA vaccine (PAN-NeoVax), injected directly into tumors, is safe and tolerable for adults with advanced solid tumors who have failed second-line therapy.
-
Re-irradiation with chidamide for recurrent head and neck squamous cell carcinoma
This trial will test whether adding the drug chidamide to repeat radiation is safe and tolerable for adults whose head and neck squamous cell carcinoma has returned after prior radiotherapy.
-
Cold exposure with PD-1/PD-L1 immunotherapy in solid tumors
This phase 1 study tests whether adding controlled cold exposure to standard PD-1/PD-L1 therapy is safe and feasible in adults with solid tumors.
-
EGFR-targeted therapy plus PD-1 blocker before surgery for advanced penile cancer
This phase II trial tests whether Becotatug vedotin plus Pucotenlimab given before surgery can shrink tumors in men with advanced penile cancer and help preserve the penis when possible.
-
Early return of atrial fibrillation after pulsed field ablation and long‑term risk
We will see if early return of AF after pulsed field ablation predicts later recurrence in adults having their first ablation.
-
MSH2-/- tumor cell vaccine for advanced pMMR (MSS) colorectal cancer
This early-phase test will see if an MSH2-/- tumor cell vaccine is safe and can stimulate an immune response and anti-tumor activity in adults with advanced pMMR (MSS) colorectal cancer who have exhausted or declined standard treatments.
-
Multidisciplinary treatment planning for older people with lung cancer
We will test a team-based approach that uses geriatric assessments to create personalized treatment plans for people aged 60–90 with newly diagnosed lung cancer to see if it improves 3-year progression-free survival compared with past patients.
-
Pre-surgery sacituzumab govitecan plus tagitanlimab for operable head and neck squamous cell carcinoma
This trial tests whether giving sacituzumab govitecan together with tagitanlimab before surgery helps people with resectable head and neck squamous cell carcinoma have better tumor responses and outcomes.
-
Y90 liver radiation plus immunotherapy and targeted drug for unresectable liver cancer
This test will see if adding Y90 liver radiation to nivolumab, ipilimumab, and lenvatinib helps people with unresectable hepatocellular carcinoma live longer and have better tumor responses.
-
Nurse-led preemptive symptom management for head and neck cancer patients during radiation therapy
This project will try a nurse-led preemptive symptom management protocol to see if it reduces radiation therapy interruptions and eases symptoms for adults receiving radiotherapy for head and neck cancer.
-
PULSAR plus Fecal Microbiota Transplantation for advanced HCC after targeted-immunotherapy
This study tests whether adding FMT and a PULSAR radiotherapy approach to the original targeted-immunotherapy can help patients with advanced hepatocellular carcinoma who progressed after first-line therapy.
-
GV20-0251 with sintilimab given before surgery for resectable head and neck cancer
This treatment combination will be given before surgery to test safety and early anti-tumor activity in adults with resectable, locally advanced head and neck squamous cell carcinoma.
-
Pringle maneuver and later gallbladder problems after liver resection
This retrospective review will test whether temporarily clamping blood flow to the liver during hepatectomy raises the chance of gallstones or gallbladder inflammation in people whose gallbladder was preserved.
-
Surgery vs. Watch-and-Wait for patients with hepatocellular carcinoma who respond to conversion therapy
This study tests whether surgical removal of liver tumors is better or worse than continuing with watchful waiting in people with HCC who have already responded to conversion therapy and are eligible for liver resection.
-
YMN-136 vaccine for liver-metastatic colorectal cancer after third-line treatment
A small, early-stage study tests whether the YMN-136 vaccine is safe and can be given at increasing doses to adults with colorectal cancer that has spread to the liver after failing at least three prior treatments.
-
H101 Plus TACE for advanced head and neck cancer
This study tests whether adding H101 to transarterial chemoembolization can help treat recurrent or metastatic head and neck squamous cell carcinoma.
-
Becotatug Vedotin with or without Immunotherapy before surgery for locally advanced head and neck cancer
This trial tests Becotatug Vedotin alone or together with immune checkpoint inhibitors to see if pre-surgery treatment can improve outcomes for people with resectable locally advanced head and neck squamous cell carcinoma.
-
Clinical characteristics and one-year outcomes of chronically critically ill adults in China
This project will measure one-year survival and long-term outcomes in adults in China who become chronically critically ill after prolonged ICU stays.
-
Topical Meilian Fuxin liquid to prevent radiation dermatitis in head and neck cancer
This trial will test whether applying Meilian Fuxin liquid to the skin twice daily can prevent radiation dermatitis in people receiving radiotherapy for head and neck cancer.
-
Traditional Chinese oral solution and mouthwash to shorten severe radiation-induced mouth sores in head and neck cancer.
This trial will try a combined traditional Chinese oral solution and mouthwash to shorten and ease severe radiation-induced mouth sores in adults receiving radiotherapy for head and neck cancer.
-
Auditory and touch stimulation to help people wake after general anesthesia
This trial will try verbal cues plus shoulder tapping or shaking during emergence to see if adults having laparoscopic abdominal surgery wake faster and more smoothly from general anesthesia.
-
BALANCE: Concurrent thrombolysis for AIS with elevated pre-treatment BP
In people having an acute ischemic stroke with high blood pressure, the BALANCE trial tests whether starting thrombolysis at the same time as BP-lowering treatment is safe and effective enough to consider it instead of waiting for BP to drop first.
-
Anti-fog suction device during endoscopic pituitary surgery
This trial tests whether an anti-fog suction device helps keep the view clear during pituitary tumor surgery and whether it lowers brain-fluid infection risk compared with the usual water-squirting method.
-
Single suprachoroidal JWK010 gene therapy injection for children with OCA1A
This trial will try a single suprachoroidal injection of JWK010 gene therapy in children aged 5–12 with TYR-related OCA1A to see if it restores retinal pigment and improves vision.
-
Integrated wearable-based perioperative care for NSCLC patients undergoing thoracic surgery
This study tests whether a wearable-enabled digital perioperative rehab program improves recovery for adults with NSCLC having thoracic surgery compared with standard care.
-
Web-based nutrition management for people with cancer
This project will try a smartphone app to help adults with cancer in Chengdu spot nutrition risks, get dietary advice, and be referred to clinical dietitians.
-
Folate-targeted NIR-II carbon dot imaging to detect HCC in removed liver tissue
This will test a folate-targeted near-infrared probe on removed liver tissue to see if it helps identify hepatocellular carcinoma margins and tiny lesions in patients undergoing radical hepatectomy.
-
Transarterial ICG-guided laparoscopic anatomical liver resection for hepatocellular carcinoma
This study tests whether using trans-arterial indocyanine green (ICG) dye to guide laparoscopic anatomical liver resection reduces cancer recurrence in people with hepatocellular carcinoma compared with the conventional portal-vein ICG method.
-
NIR‑II fluorescence guidance with ICG‑cisplatin nanoprobes for liver tumor resection
This study tries a new ICG‑cisplatin nanoprobe injected through the liver artery to help surgeons see and remove single small hepatocellular carcinomas during laparoscopic anatomic hepatectomy.
-
PULSAR with dual immunotherapy and chemotherapy for cholangiocarcinoma
This trial will test whether adding PULSAR radiotherapy to two immunotherapy drugs plus gemcitabine and cisplatin helps people with locally advanced or metastatic cholangiocarcinoma.
-
TCM oral liquid plus herbal mouthwash for radiation‑caused mouth sores in head and neck cancer
This study will test whether taking a Qingying oral liquid and using a modified Da Huang‑Huang Lian Xiexin mouthwash can reduce how often, how long, and how severe radiation‑induced mouth sores are in adults receiving radiotherapy for head and neck cancer.
-
Response-adapted total neoadjuvant therapy guided by induction chemotherapy to enable a watch-and-wait approach for low rectal cancer
This project will see if people with mid-to-low rectal cancer who respond well to induction chemotherapy can avoid immediate surgery and be safely managed with a watch-and-wait approach after completing total neoadjuvant therapy.
-
Short-course radiotherapy plus immunochemotherapy before surgery for gastroesophageal junction cancer
This will test whether giving short-course (hypofractionated) radiotherapy together with a PD-1 drug (serplulimab) and TS-1 chemotherapy before surgery helps people with locally advanced, resectable gastroesophageal junction adenocarcinoma.
-
Sirolimus Withdrawal Strategies for Kaposiform Hemangioendothelioma
This study tests how to safely stop sirolimus in people with Kaposiform Hemangioendothelioma to see if disease stays controlled after withdrawal.
-
Testing GV20-0251 for advanced or treatment‑resistant solid tumors
This study will test whether GV20-0251 is safe and tolerable when given every three weeks to adults with advanced or treatment‑resistant solid tumors such as liver, lung, pancreatic cancer, and melanoma.
-
Patient-reported and clinical outcomes after Chidamide plus sintilimab (± bevacizumab) for MSS advanced colorectal cancer
This project will see how well Chidamide combined with sintilimab, with or without bevacizumab, is tolerated and reported by Chinese adults with MSS advanced colorectal cancer receiving it in routine care.
-
GnP plus serplulimab with stereotactic body radiation therapy for first-line locally advanced pancreatic cancer.
This trial will test whether combining GnP chemotherapy, the immunotherapy serplulimab, and focused SBRT helps people aged 18–75 with untreated, locally advanced pancreatic ductal adenocarcinoma.
-
IL-22BP mRNA vaccine for refractory advanced solid tumors
This trial will test an IL-22BP mRNA vaccine in lipid nanoparticles to see if it is safe and can slow or shrink advanced solid tumors in adults who have failed standard second-line treatments.
-
Prussian blue nanozyme with near-infrared heat to heal severe radiation dermatitis after head and neck radiotherapy
This will try a Prussian blue–based nanozyme together with near-infrared heat therapy to help heal Grade III radiation dermatitis in people receiving high‑dose radiotherapy for head and neck cancer.
-
Amino acid–derived antioxidant lipids to prevent and treat radiation skin damage in head and neck cancer
This trial will try a new amino acid–based lipid treatment that soaks up harmful reactive oxygen species to prevent or lessen radiation dermatitis in people receiving high‑dose radiotherapy for head and neck cancer.
-
HBV mRNA vaccine to lower HCC recurrence around liver transplant
This trial will test whether an HBV-targeted mRNA vaccine can reduce hepatocellular carcinoma recurrence in adults with hepatitis B who are awaiting or undergoing liver transplantation.
-
Zusanli (ST36) electroacupuncture plus immunotherapy in NSCLC before surgery
This trial tests whether adding electroacupuncture at ST36 to standard neoadjuvant immunotherapy helps patients with NSCLC better respond to treatment.
-
Canagliflozin for metastatic MSI-H colorectal cancer
This will try canagliflozin, a diabetes drug, in adults with metastatic MSI-H colorectal cancer to see if it is safe and helps control tumor growth.
-
Short-course higher-dose radiotherapy plus immunochemotherapy to make gastroesophageal junction cancer removable
This test adds short-course, higher-dose radiotherapy to PD-1 immunotherapy (sintilimab) and SOX chemotherapy for adults with locally advanced or initially unresectable gastroesophageal junction adenocarcinoma to see if tumors shrink enough for surgery.
-
Planned organ preservation after neoadjuvant chemotherapy for low rectal cancer
This trial tests whether adding immunotherapy to long-course chemoradiotherapy and consolidation chemotherapy helps more people with low to intermediate-risk low rectal cancer keep their rectum after an initial good response to XELOX chemotherapy.
-
ROS-scavenging nanoenzyme prevention for radiation dermatitis in head and neck cancer
This trial will try to see if giving novel ROS-scavenging nanoenzymes can prevent radiation-related skin damage in people receiving high-dose radiotherapy for head and neck cancer.
-
MRG003 plus HX008 for EGFR-positive advanced or metastatic penile squamous cell carcinoma
This trial tests whether combining the EGFR-targeted antibody-drug conjugate MRG003 with the PD-1 inhibitor HX008 works as a first-line treatment for men with EGFR-positive advanced or metastatic penile cancer.
-
PD-1 mRNA lipid‑nanoparticle vaccine for advanced liver cancer
This trial will try a PD‑1 mRNA vaccine delivered in lipid nanoparticles as a treatment for adults with advanced hepatocellular carcinoma who have not responded to standard therapies.
-
WGc0201 mRNA vaccine for people with chronic hepatitis B
This Phase I trial will test whether the WGc0201 mRNA vaccine is safe and can lower viral markers in adults with stable chronic hepatitis B who are on antiviral therapy.
-
Spermidine to prevent radiation-induced dry mouth in head and neck cancer
This trial will try if taking spermidine capsules twice daily during radiotherapy prevents dry mouth in adults with head and neck cancer.
-
DCSZ11 combined with standard therapy for advanced or metastatic solid tumors
This will test whether adding DCSZ11 to standard treatments helps adults with advanced or metastatic solid tumors.
-
Personalized long-course radiotherapy and chemotherapy, with or without immunotherapy, for locally advanced rectal cancer
This study tests whether adding the immunotherapy drug serplulimab to personalized long-course radiotherapy and chemotherapy helps adults with locally advanced rectal cancer achieve complete tumor disappearance.
-
HUAXI Hole 1–assisted reverse‑sequence endoscopic nipple‑sparing mastectomy with immediate implant reconstruction
This project will test whether adding a 2‑mm 'HUAXI Hole 1' near the areola makes reverse‑sequence endoscopic nipple‑sparing mastectomy with direct‑to‑implant reconstruction faster, safer, and more cosmetic for women with early‑stage breast cancer or undergoing prophylactic mastectomy.
-
Evaluating laparoscopic right hemihepatectomy for liver cancer
This study is testing if a less invasive liver surgery for cancer can be safer and lead to better recovery than traditional surgery for people with liver cancer.
-
Evaluating the effects of adjuvant therapy after surgery for liver cancer
This study is testing if additional treatment after surgery can help people with a rare and aggressive type of liver cancer do better.
-
Using hydroxychloroquine to prevent and treat oral mucositis from radiation therapy
This study is testing if hydroxychloroquine can help prevent and treat mouth sores in people getting radiation therapy for head and neck cancer.
-
Engineered mitochondrial vaccine for advanced solid tumors
This study is testing a new vaccine made to help boost the immune system against advanced solid tumors in patients who can't or don't want to use standard treatments.
-
Using AI to improve wrist and hand joint ultrasound imaging
This study is testing whether an AI system can help sonographers who are new to hand and wrist ultrasound scans do a better job by quickly identifying important structures during the imaging process.
-
Polyphenol whole-tumor-cell vaccine for adults with advanced solid tumors
This phase 1 trial will try a polyphenol-treated whole tumor cell vaccine to see if it's safe and tolerable in adults with advanced metastatic solid tumors who have already received prior therapies.
-
Combining HAIC with Durvalumab and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma
This study is testing a new treatment combining chemotherapy with two other drugs to see if it can help people with advanced bile duct cancer feel better and live longer.
-
Combining PD-1 inhibitor with Apatinib and Mitotane for advanced adrenal cancer treatment
This study is testing a new combination of three medications to see if it can help people with advanced adrenal cancer who haven't had treatment yet.
-
Using deep learning to identify tumor origins from lymph node samples
This study is trying to see if a new computer program can help find out where tumors that spread to lymph nodes come from, and how it compares to the work of human doctors.
-
Online follow-up for patients with papillary thyroid cancer
This study is testing if online follow-up visits are just as good as in-person check-ups for people who have had surgery for papillary thyroid cancer.
-
Different starting doses of oral propranolol for ulcerated infantile hemangioma
This trial sees if different starting doses of oral propranolol help heal ulcerated infantile hemangiomas and are safe for infants.
-
Effects of esketamine and lidocaine on pain and survival after liver surgery
This study is testing if a combination of esketamine and lidocaine can help reduce pain and improve survival for people having liver surgery for cancer compared to standard pain relief methods.
-
Combining afatinib and palbociclib for previously treated advanced esophageal squamous cell carcinoma
This trial tests whether taking afatinib together with palbociclib helps control tumor growth in people with recurrent or metastatic esophageal squamous cell carcinoma who have already received prior treatments.
-
Combining PD-L1 antibody and Bevacizumab with chemotherapy for advanced liver cancer
This study is testing a new combination of treatments for people with advanced liver cancer to see if it can help them live longer and feel better.
-
Combining XELOX chemotherapy, sintilimab, and hyperbaric oxygen therapy for advanced gastric cancer
This study is testing a new combination of chemotherapy, an immune therapy, and oxygen treatment to see if it can help people with advanced stomach cancer feel better and improve their treatment outcomes.
-
Using sirolimus to treat cystic lymphatic malformations in children
This study is testing different doses of sirolimus to see if it can safely help children with cystic lymphatic malformations.
-
Web-based platform for managing cancer pain
This study is testing a new app that helps people with cancer pain in rural China track their symptoms and communicate better with their doctors.
-
SBRT plus PD-1 immunotherapy and chemotherapy for early-stage triple-negative breast cancer
This tests whether adding stereotactic body radiotherapy (SBRT) to a PD-1 drug and chemotherapy helps people with early-stage triple-negative breast cancer get better responses to treatment.
-
Observing physiological changes in ARDS patients in the prone position
This study looks at how lying on the stomach affects breathing and oxygen levels in patients with Acute Respiratory Distress Syndrome to see if it can help improve their recovery.
-
Identifying brain biomarkers for treating obsessive-compulsive disorder with deep brain stimulation
This study is testing if deep brain stimulation can help people with obsessive-compulsive disorder who haven't found relief from regular treatments by looking for brain signals that might predict their symptoms.
-
Identifying brain biomarkers for treatment-resistant major depression using deep brain stimulation
This study is testing if deep brain stimulation can help people with severe depression who haven't found relief from regular treatments by looking for brain signals that could predict their mood changes.
-
Evaluating JWK008 for Mucopolysaccharidosis Type I
This study is testing a new gene therapy called JWK008 to see if it can safely help people with Mucopolysaccharidosis Type I by improving their symptoms.
-
Using organoid testing to find effective treatments for advanced thyroid cancer
This study tests if using lab-grown mini tumors can help find the best treatments for people with advanced thyroid cancer to improve their outcomes and lower surgery risks.
-
Neoadjuvant immunotherapy combined with chemotherapy for advanced head and neck cancer
This study is testing whether combining three different immunotherapy drugs with chemotherapy can help people with advanced head and neck cancer before surgery.
-
Combining cadonilimab with chemotherapy for advanced bile duct cancer
This study is testing if combining a new drug called cadonilimab with chemotherapy can help people with advanced bile duct cancer who haven't responded to other treatments.
-
Using Bleomycin for treating lymphatic malformations in children
This study is testing whether different strengths of Bleomycin can safely treat lymphatic malformations in children under 14 that can't be removed with surgery.
-
Lidocaine's effects on pain and survival in elderly colorectal surgery patients
This study is testing if giving lidocaine during colorectal surgery can help older patients manage pain better, improve their quality of life, and live longer after the surgery.
-
Individualized blood management for non-cardiac surgeries
This study tests whether a personalized blood management technique can help adults having non-cardiac surgeries avoid needing blood transfusions.
-
Organ function changes after open necrosectomy for infected necrotizing pancreatitis with sepsis
This project will see if organ function improves or worsens after open necrosectomy in adults with infected necrotizing pancreatitis and sepsis.
-
AI app to help manage atopic dermatitis
This study is testing a new AI app designed to help people with atopic dermatitis manage their skin condition better by using images to track and evaluate their symptoms.
-
Gene therapy for X-linked retinoschisis in children and adolescents
This study is testing a new gene therapy for boys aged 5 to 18 with X-linked retinoschisis to see if it can improve their vision and eye health.
-
Using irinotecan liposomes with chemotherapy for advanced colorectal cancer
This study is testing if a new way of giving irinotecan with chemotherapy can help people with advanced colorectal cancer live longer and feel better.
-
Effect of electrical stimulation on pain and recovery after liver surgery
This study is testing if a special electrical treatment can help reduce pain and speed up recovery for people having liver surgery for cancer.
-
Assessing muscle loss in lung cancer patients using imaging techniques
This study is testing a new way to use ultrasound and scans to find muscle loss in lung cancer patients to see if catching it early can help improve their treatment and recovery.
-
Investigating long-term effects of sepsis in critically ill children
This study looks at how sepsis affects critically ill children over five years to see how it impacts their growth, brain development, survival, and quality of life after leaving the hospital.
-
Using ctDNA to improve chemotherapy for stage III colon cancer
This study is testing whether using blood tests to check for tumor DNA can help doctors give better chemotherapy to people with stage III colon cancer after surgery.
-
Using a new method of indocyanine green for liver surgery imaging
This study is testing a new way of using a special dye during liver surgery to see if it helps doctors find tumors better compared to the usual method, and it's for patients with liver cancer.
-
Using ultrasound and AI to diagnose sarcopenia in older adults
This study is testing if using ultrasound and artificial intelligence can help doctors better diagnose muscle loss in older adults to improve their health and quality of life.
-
Intrathecal immune checkpoint blocker plus pemetrexed for leptomeningeal spread of NSCLC
This study will try injecting an immune checkpoint blocker together with pemetrexed into the spinal fluid to see if it helps people with non-small cell lung cancer that has spread to the membranes around the brain and spinal cord.
-
Combining Lenvatinib, TACE, and Camrelizumab for Advanced Liver Cancer Treatment
This study is testing a new combination treatment of lenvatinib, TACE, and camrelizumab to see if it helps people with advanced liver cancer live longer compared to using lenvatinib and TACE alone.
-
Combining camrelizumab, apatinib, and chemotherapy for treating triple negative breast cancer
This study tests if a new combination of camrelizumab, apatinib, and chemotherapy can help shrink tumors and improve outcomes for patients with early or locally advanced triple negative breast cancer before surgery.
-
Predicting outcomes and guiding antiplatelet treatment after PCI for people at high bleeding risk
This project uses medical records and AI to see what predicts worse outcomes and which antiplatelet medicines and treatment lengths are used in adults who had PCI and are at high risk of bleeding.
-
Comparing radiotherapy alone to radiotherapy with temozolomide for treating high-risk low-grade gliomas after surgery
This study is testing if adding a chemotherapy drug called temozolomide to radiotherapy helps people with high-risk low-grade brain tumors live longer and healthier after surgery.
Quick answers
How many clinical trials run by West China Hospital are recruiting right now?
126, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 29, Phase 2: 25, Phase 1/2: 12, Phase 3: 6. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.